HIMS

Hims & Hers is one of the most talked-about stocks in the market. It is also one of the most volatile stocks . The stock has risen by 250% over the past five years , but if you look at it over the past year, the stock has fallen by about 50%. There's a lot going on inside the company.

Personally, my two favorite cheap stocks, well let me add a third, are SoFi, American Airlines, and Hims.

I want to talk about the company "Hems & Hers Health". This is another name that is attracting a lot of attention, especially on social media. It's a volatile stock, but it seems to be in a transitional phase, and I'm interested to know your opinion on its role in this area, and your general opinion of the company .

Hims & Hers management team reiterated its longer-term guidance to investors. The management team is forecasting at least $6.5 billion in revenue by 2030 and $1.3 billion in adjusted earnings before interest, taxes, depreciation, and amortization.

But does this make Hims & Hers stock a buying opportunity for long-term investors? So, revenue of at least $6 billion by 2030 would be more than double their most recent trailing 12-month total.

In that period, Hims & Hers reported $2.6 billion in revenue. That's up from around $250 million in 2020. This has been one of the fastest-growing companies in the world.